• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Sunday, June 4, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Henry Ford Health cardiologists first in Michigan to use heart recovery technology

Bioengineer by Bioengineer
April 25, 2023
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

DETROIT (April 25, 2023) – Interventional cardiologists at Henry Ford Health are the first in Michigan to treat a patient using the Impella RP Flex with SmartAssist, one of the world’s smallest heart pumps.

Impella RP Flex with SmartAssist Pump

Credit: Courtesy of Abiomed

DETROIT (April 25, 2023) – Interventional cardiologists at Henry Ford Health are the first in Michigan to treat a patient using the Impella RP Flex with SmartAssist, one of the world’s smallest heart pumps.

The innovative pump, which provides temporary right heart mechanical circulatory support, allows Henry Ford Health physicians provide more comprehensive and advanced care options to patients in Michigan experiencing acute right heart failure.

“Henry Ford Health is recognized as the leading provider of cardiovascular care in our region and beyond,” said Alaswad Khaldoon, M.D., an interventional cardiologist and medical director of the Cardiac Catheterization Laboratory at Henry Ford Hospital. “The new heart pump provides our physicians an innovative tool to treat patients experiencing right heart failure.”

The Impella RP Flex technology received U.S. FDA pre-market approval in October 2022 as safe and effective to treat acute right heart failure or decompensation for up to 14 days following left ventricular assist device implantation, myocardial infarction, heart transplant or open-heart surgery. The pump is implanted via the internal jugular vein, which enables patient mobility, and its dual-sensor technology is designed to optimize patient management.

“The heart pump’s novel technology allows us to treat right heart failure more effectively,” said Akshay Khandelwal, M.D., MBA, an interventional cardiologist and associate division head of Cardiology at Henry Ford Health. “By allowing a patient’s own heart to rest and recover, we can help improve their quality of life.”

Henry Ford Health Heart & Vascular teams specialize in diagnosing and treating cardiovascular conditions using minimally invasive techniques. Many of these procedures take place in cardiac catheterization labs. The cardiac cath lab is a special examination room featuring state-of-the-art equipment and specially trained staff who carry out procedures using catheters to access patients’ hearts and surrounding structures through tiny incisions. Henry Ford Hospital was also first in Michigan to use the radial approach technique to access the heart using radial artery in patients’ wrists, allowing most patients to go home the same day as their procedure.

Globally, more than 250,000 patients have benefited from the Impella heart pump support, developed by Abiomed, a medical device technology company based in Massachusetts.

Visit henryford.com/services/heart-and-vascular to learn more about Henry Ford Health’s Heart and Vascular services.

###

 

MEDIA ONLY MAY CONTACT: Sal Giacona / [email protected] / 313-421-9108

 

ABOUT HENRY FORD HEALTH
Serving communities across Michigan and beyond, Henry Ford Health is committed to partnering with patients and members along their entire health journey. Henry Ford Health provides a full continuum of services – from primary and preventative care, to complex and specialty care, health insurance, a full suite of home health offerings, virtual care, pharmacy, eye care and other healthcare retail.

It is one of the nation’s leading academic medical centers, recognized for clinical excellence in cancer care, cardiology and cardiovascular surgery, neurology and neurosurgery, orthopedics and sports medicine, and multi-organ transplants. Consistently ranked among the top five NIH-funded institutions in Michigan, Henry Ford Health engages in more than 2,000 research projects annually. Equally committed to educating the next generation of health professionals, Henry Ford Health trains more than 4,000 medical students, residents and fellows every year across 50+ accredited programs.

With more than 33,000 valued team members, Henry Ford Health is also among Michigan’s largest and most diverse employers, including nearly 6,000 physicians and researchers from the Henry Ford Medical Group, Henry Ford Physician Network and Jackson Health Network.

The health system is led by President and CEO Robert G. Riney and serves a growing number of customers across 250+ locations throughout Michigan including five acute care hospitals, two destination facilities for complex cancer and orthopedics and sports medicine care, three behavioral health facilities, primary care and urgent care centers.



Share12Tweet8Share2ShareShareShare2

Related Posts

Dr. Alex Herrera

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

June 4, 2023
Ana Oaknin, Principal Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Gynecological Malignancies Group

The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

June 3, 2023

Carbon-based stimuli-responsive nanomaterials: classification and application

June 3, 2023

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

June 3, 2023

POPULAR NEWS

  • plants

    Plants remove cancer causing toxins from air

    40 shares
    Share 16 Tweet 10
  • Element creation in the lab deepens understanding of surface explosions on neutron stars

    36 shares
    Share 14 Tweet 9
  • Deep sea surveys detect over five thousand new species in future mining hotspot

    35 shares
    Share 14 Tweet 9
  • How life and geology worked together to forge Earth’s nutrient rich crust

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

Carbon-based stimuli-responsive nanomaterials: classification and application

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 50 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In